Search Results

Global programme to eliminate lymphatic filariasis: progress report, 2022.

Subjects: *ELEPHANTIASIS; *LYMPHEDEMA; *PUBLIC health surveillance

• Source: Weekly Epidemiological Record. 10/13/2023, Vol. 98 Issue 41, p489-502. 14p.

Record details

Global programme to eliminate lymphatic filariasis: progress report, 2021.

Subjects: *ELEPHANTIASIS; *DISEASE eradication; *WORLD healthFRANCEWORLD Health Organization

• Source: Weekly Epidemiological Record. 10/14/2022, Vol. 97 Issue 41, p513-524. 12p.

Record details

Global programme to eliminate lymphatic filariasis: progress report, 2023.

Subjects: WORLD Health Organization; INFECTION control; DRUG administration

• Source: Weekly Epidemiological Record. 10/4/2024, Vol. 99 Issue 40, p565-576. 12p.

Record details

Global programme to eliminate lymphatic filariasis: progress report, 2020.

Subjects: *ELEPHANTIASIS; *REPORT writing; *COVID-19

• Source: Weekly Epidemiological Record. 10/15/2021, Vol. 96 Issue 41, p497-508. 12p.

Record details

Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation.

• Authors : Toor, Jaspreet¹; Adams, Emily R²; Aliee, Maryam^3,4

Subjects: *NEGLECTED diseases; *ELEPHANTIASIS; *HELMINTHIASIS

• Source: Clinical Infectious Diseases. 4/15/2021, Vol. 72 Issue 8, p1463-1466. 4p.

Record details

Education Full Text (H.W. Wilson)

Record details

Coverage evaluation of Mass Drug Administration (MDA) for lymphatic filariasis in a district of Bundelkhand Region of Uttar Pradesh.

• Authors : Barman, Santosh Kumar¹; Kumar, Navin²; Barman, Seema

Subjects: *ELEPHANTIASIS; *DISEASE eradication; *CROSS-sectional methodINDIA

• Source: Indian Journal of Community Health. Jun2022, Vol. 34 Issue 2, p170-175. 6p.

Record details

Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.

• Authors : Oliver, Mary Chriselda Antony; Graham, Matthew; Gass, Katherine M

Subjects: COST effectiveness; INFECTION control; RESEARCH fundingTANZANIA; HAITI; INDIA

• Source: Clinical Infectious Diseases; 2024 Supplement, Vol. 78, pS160-S168, 9p

Record details

How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?

• Authors : Kura, Klodeta; Stolk, Wilma A; Basáñez, Maria-Gloria

Subjects: COMBINATION drug therapy; RESEARCH funding; DRUG administration

• Source: Clinical Infectious Diseases; 2024 Supplement, Vol. 78, pS93-S100, 8p

Record details

Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings.

• Authors : James, Ananthu; Coffeng, Luc E; Blok, David J

Subjects: COMBINATION drug therapy; PREDICTIVE tests; BIOLOGICAL modelsINDIAWORLD Health Organization

• Source: Clinical Infectious Diseases; 2024 Supplement, Vol. 78, pS131-S137, 7p

Record details